Log In
Print this Print this

ordopidine (ACR325)

  Manage Alerts
Collapse Summary General Information
Company NeuroSearch A/S
DescriptionDopamine stabilizer
Molecular Target Not available
Mechanism of ActionDopamine stabilizer
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationHyperkinetic movement disorder
Indication DetailsTreat dyskinesia in patients with Parkinson's disease (PD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today